Human Health
Rapid and precise infectious disease screening.
BioDExSA PRO LLCKing Abdullah University of Science and Technology (KAUST), Thuwal, Kingdom of Saudi Arabia
PioneeringDiagnostic Localizationin Saudi Arabia
Securing the Kingdom's Biosecurity
Scroll
01Introduction
Welcome to BioDExSA PRO
BioDExSA PRO LLC is a premier biotechnology early mover in the Kingdom of Saudi Arabia, established in 2025 in Jeddah.
We are strategically positioned to lead the domestic localization, development, and high-standard manufacturing of advanced diagnostic kits. By bridging the gap between global innovations and national infrastructure, we serve the clinical, industrial, and public health sectors with unmatched reliability.
Founder & CEODr. Faris Altaf
- ClinicalDiagnostics for human health
- IndustrialAssays for regulated supply chains
- Public HealthNational surveillance capability
02The Philosophy and Meaning Behind Our Name
Our name is our strategic blueprint
Five deliberate pillars, each committing us to a specific discipline together, describe exactly how diagnostic capability is built inside the Kingdom.
Bio
Biotechnology
Represents the scientific foundation on which we build native, resilient diagnostic capabilities.
DE
Developing
Stands for actively engineering biotech solutions from the ground up in Saudi Arabia.
Ex
Exchange
Reflects the exchange of know-how from global diagnostic leaders into the Saudi market.
SA
Saudi Arabia
Signals our proud identity as a Saudi company, under scientific and R&D leadership specifically tailored for the Kingdom.
PRO
Professionalism
Embodies our commitment to building trusted connections with global partners, uniting expertise and technology through elite collaborations that enable seamless technology transfer and sustainable localization.
BioDExSA PRO
Five strategic pillars, one continuous commitment from the science at our core to the standard we hold ourselves to.
03Strategic Localization
Saudi Capability.Global Standards.
Localization is not relocation. It is the deliberate transfer of scientific know-how into domestic hands — until the capability to design, validate and manufacture a diagnostic lives entirely within the Kingdom.
Localization
Bringing the full diagnostic value chain — design, assembly, quality control — onto Saudi ground.
Knowledge Transfer
Structured exchange with global diagnostic leaders, so expertise stays after the technology arrives.
Scientific Capability
Building the specialist depth that lets Saudi teams lead development rather than follow it.
Diagnostic Sovereignty
The ability to detect what matters to the Kingdom without depending on external supply.
Advanced Manufacturing
High-standard production disciplines applied to diagnostic kits built for local conditions.
Resilient Supply Chains
Domestic laboratory networks that hold under pressure, not only under normal conditions.
Research & Development
Continuous R&D leadership tailored to the pathogens, populations and priorities of the Kingdom.
04National Biosecurity
Securing the Kingdom's Biosecurity
National resilience requires self-reliance. BioDExSA PRO explicitly aims to fortify Saudi Arabia's defense against biological threats by supplying locally manufactured diagnostic solutions across four critical sectors:
Diagram: four diagnostic sectors — human health, food safety, animal health and environmental monitoring — connected to a single national biosecurity ecosystem.
Food Safety
Assays designed to safeguard the local supply chain.
Animal Health
Veterinary diagnostics to support livestock and agricultural security.
Environmental Monitoring
Systems tracking ecological health and pathogen variants.
BiosecurityOne ecosystem
05Our Method
From Science to Sovereign Capability
A diagnostic does not become national capability at the moment it is invented. It becomes national capability at the end of a disciplined sequence.
Research
Scientific groundwork defines what the Kingdom actually needs to detect.
Technology Exchange
Know-how moves from global diagnostic leaders into Saudi teams.
Localization
The method is rebuilt for domestic conditions, materials and networks.
Validation
Performance is proven against the standards clinical use demands.
Manufacturing
High-standard domestic production turns a validated method into supply.
Deployment
Kits reach clinical, industrial and public health sectors across the Kingdom.
06National Ambition
Built for a More Resilient Kingdom
A nation that can diagnose itself can defend itself. Every assay developed and manufactured on Saudi ground shortens the distance between a biological threat and the Kingdom's response to it.
That is the work: converting global scientific innovation into capability that stays — held by Saudi laboratories, Saudi manufacturing and Saudi scientists.
Self-reliance
Capability held domestically, not imported under pressure.
Readiness
Detection capacity that exists before it is needed.
Continuity
Supply that does not depend on external conditions.
Partnership
Building Saudi Arabia's Diagnostic Future.
Transforming global scientific innovation into resilient national capability.